These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10529625)

  • 1. Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants.
    Saito T; Oikawa S; Sato H; Sasaki J
    Nephron; 1999; 83(3):193-201. PubMed ID: 10529625
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare cause of posttransplantation nephrotic syndrome.
    Foster K; Matsunaga A; Matalon R; Saito T; Gallo G; D'Agati V; Stokes MB
    Am J Kidney Dis; 2005 Jun; 45(6):1132-8. PubMed ID: 15957145
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney.
    Miyata T; Sugiyama S; Nangaku M; Suzuki D; Uragami K; Inagi R; Sakai H; Kurokawa K
    J Am Soc Nephrol; 1999 Jul; 10(7):1590-5. PubMed ID: 10405216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
    Saito T; Matsunaga A
    J Atheroscler Thromb; 2011; 18(6):542-3. PubMed ID: 21670560
    [No Abstract]   [Full Text] [Related]  

  • 6. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein glomerulopathy: a pediatric case report.
    Maruyama K; Arai H; Ogawa T; Tomizawa S; Morikawa A
    Pediatr Nephrol; 1997 Apr; 11(2):213-4. PubMed ID: 9090668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
    Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
    J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular cardiac lipoproteinosis: extrarenal manifestation of lipoprotein glomerulopathy.
    Morris CS; Bois MC; Aust CH; Thomas R; Sethi S; Maleszewski JJ
    Cardiovasc Pathol; 2019; 42():6-9. PubMed ID: 31158730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
    Xie W; Xie Y; Lin Z; Xu X; Zhang Y
    Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy.
    Ogawa T; Maruyama K; Hattori H; Arai H; Kondoh I; Egashira T; Watanabe T; Kobayashi Y; Morikawa A
    Pediatr Nephrol; 2000 Feb; 14(2):149-51. PubMed ID: 10684367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.
    Stratikos E; Chroni A
    Clin Exp Nephrol; 2014 Apr; 18(2):225-9. PubMed ID: 24149834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy.
    Konishi K; Saruta T; Kuramochi S; Oikawa S; Saito T; Han H; Matsunaga A; Sasaki J
    Nephron; 1999; 83(3):214-8. PubMed ID: 10529627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel apolipoprotein E mutation (p.Arg150Cys) in a Chinese patient with lipoprotein glomerulopathy.
    Ku M; Tao C; Zhou AA; Cheng Y; Wan QJ
    Chin Med J (Engl); 2019 Jan; 132(2):237-239. PubMed ID: 30614865
    [No Abstract]   [Full Text] [Related]  

  • 17. A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.
    Boumendjel R; Papari M; Gonzalez M
    Arch Pathol Lab Med; 2010 Feb; 134(2):279-82. PubMed ID: 20121619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E deficiency and high-fat diet cooperate to trigger lipidosis and inflammation in the lung via the toll-like receptor 4 pathway.
    Ouyang Q; Huang Z; Lin H; Ni J; Lu H; Chen X; Wang Z; Lin L
    Mol Med Rep; 2015 Aug; 12(2):2589-97. PubMed ID: 25975841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New evolution in lipoprotein glomerulopathy].
    Saito T; Matsunaga A; Nakashima H
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1314-9. PubMed ID: 24288968
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
    Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
    Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.